Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-03-05 @ 1:11 AM
Study NCT ID:
NCT00383851
Status:
UNKNOWN
Last Update Posted:
2007-12-06
First Post:
2006-10-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma
Sponsor:
Attenuon
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ATN-224-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None